Cargando…
Feasibility of β-Sheet Breaker Peptide-H102 Treatment for Alzheimer's Disease Based on β-Amyloid Hypothesis
β-amyloid hypothesis is the predominant hypothesis in the study of pathogenesis of Alzheimer's disease. This hypothesis claims that aggregation and neurotoxic effects of amyloid β (Aβ) is the common pathway in a variety of etiological factors for Alzheimer's disease. Aβ peptide derives fro...
Autores principales: | Lin, Lai-xiang, Bo, Xiang-yu, Tan, Yuan-zhen, Sun, Feng-xian, Song, Ming, Zhao, Juan, Ma, Zhi-hong, Li, Mei, Zheng, Kai-jun, Xu, Shu-mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221228/ https://www.ncbi.nlm.nih.gov/pubmed/25372040 http://dx.doi.org/10.1371/journal.pone.0112052 |
Ejemplares similares
-
Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
por: Wisniewski, Thomas, et al.
Publicado: (2008) -
Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
por: Pederzoli, Francesca, et al.
Publicado: (2019) -
β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling
por: Liu, Weiying, et al.
Publicado: (2018) -
Consecutive Aromatic Residues Are Required for Improved Efficacy of β-Sheet Breakers
por: Jarmuła, Adam, et al.
Publicado: (2022) -
Assembly
of Peptides Derived from β-Sheet
Regions of β-Amyloid
por: Truex, Nicholas L., et al.
Publicado: (2016)